U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07038928) titled 'TReatment Approaches and bIomarkers preValence in bladdEr Cancer in RuSsian Federation' on June 05.
Brief Summary: A multicentre observational study on treatment approaches and HER2 positive status prevalence in different stages of bladder cancer and PD-L1-positive status in metastatic bladder cancer in Russian Federation
Study Start Date: June 30
Study Type: OBSERVATIONAL
Condition:
Bladder Cancer
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AstraZeneca
Disclaimer: Curated by HT Syndication....